Showing 44 results

Filters Content type: News, Editors' picks, About HIV Topic: Antibody-based treatment
The search for a cure

First trial results of new immune-modulating drugs presented in Mexico City

News
26 July 2019
Antibody-based treatment

Monoclonal antibody may lead to long-term viral load reduction

News
11 April 2019
People with limited treatment options

Prolonged HIV suppression is possible using ibalizumab, analysis of highly drug-resistant people shows

News
2 November 2018
The search for a cure

The Miami monkey cured with two antibodies

News
26 October 2018
New & experimental HIV treatments

Dual-antibody combination therapy produces three to seven months of viral suppression without pills

News
8 October 2018
New & experimental HIV treatments

Ibalizumab, active against highly resistant HIV, now approved in US

News
8 March 2018
The search for a cure

Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys

News
5 March 2018
Antibody-based treatment

Long-acting monoclonal antibody effective against multidrug-resistant HIV

News
12 October 2017
The search for a cure

VRC01 antibody can delay but not prevent viral rebound after interruption of early treatment

News
2 August 2017
The search for a cure

Research helps explain how vedolizumab antibody therapy leads to sustained viral remission

News
23 March 2017
New & experimental HIV treatments

Monoclonal antibodies show promise for HIV-positive people with limited treatment options

News
22 February 2017
New & experimental HIV treatments

Ibalizumab monoclonal antibody looks promising for people with drug-resistant HIV

News
4 November 2016
New & experimental HIV treatments

PRO 140 antibody injections maintain viral suppression in phase 2 study

News
28 June 2016
The search for a cure

VRC01 antibody delays but does not prevent HIV rebound after antiretroviral treatment interruption

News
8 April 2016
New & experimental HIV treatments

Dose-finding trials of antibody-based drugs for HIV prevention will start soon

News
24 February 2016
New & experimental HIV treatments

New way of attacking HIV looks promising in early trial

News
25 March 2008
New & experimental HIV treatments

ICAAC: Phase 1 study provides `proof of concept` for PRO 140, a monoclonal CCR5 antibody

News
21 September 2007
New & experimental HIV treatments

Substantial HIV reduction persists for 2-3 weeks with single dose of PRO-140 antibody

News
1 May 2007
New & experimental HIV treatments

Antibody to CCR5 receptor safe, effective, suitable for weekly dosing, preliminary study shows

News
30 September 2006
New & experimental HIV treatments

Novel antibody enters trials as HIV treatment

News
13 June 2003